BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24418620)

  • 21. Calculated low density lipoprotein cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels < or =4.52 mmol/l: an analysis comparing the LipiDirect magnetic LDL assay with the Friedewald calculation.
    Tighe DA; Ockene IS; Reed G; Nicolosi R
    Clin Chim Acta; 2006 Mar; 365(1-2):236-42. PubMed ID: 16259972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise attenuates the increase in plasma monounsaturated fatty acids and high-density lipoprotein cholesterol but not high-density lipoprotein 2b cholesterol caused by high-oleic ground beef in women.
    Gilmore LA; Crouse SF; Carbuhn A; Klooster J; Calles JA; Meade T; Smith SB
    Nutr Res; 2013 Dec; 33(12):1003-11. PubMed ID: 24267039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estimation of low density lipoprotein cholesterol concentration: regression analysis versus Friedewald's formula].
    Eblen-Zajjur A; Eblen-Zajjur M
    Rev Med Chil; 2001 Nov; 129(11):1263-70. PubMed ID: 11836878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calculated low-density lipoprotein cholesterol remains a viable and important test for screening and targeting therapy.
    Abudu N; Levinson SS
    Clin Chem Lab Med; 2007; 45(10):1319-25. PubMed ID: 17727314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?
    Sniderman A; McQueen M; Contois J; Williams K; Furberg CD
    J Clin Lipidol; 2010; 4(3):152-5. PubMed ID: 21122647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Multicenter evaluation of four homogenous LDL-cholesterol assays].
    Bayer P; Veinberg F; Couderc R; Cherfils C; Cambillau M; Cosson C; Fradin S; Gillery P; Steinmetz J; Legrand A; Egloff M; Beucler I
    Ann Biol Clin (Paris); 2005; 63(1):27-41. PubMed ID: 15689310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of alternative calculation methods for determining LDL cholesterol.
    Vohnout B; Vachulová A; Blazícek P; Dukát A; Fodor G; Lietava J
    Vnitr Lek; 2008 Oct; 54(10):961-4. PubMed ID: 19009762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new accurate, simple formula for LDL-cholesterol estimation based on directly measured blood lipids from a large cohort.
    de Cordova CM; de Cordova MM
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):13-9. PubMed ID: 23108766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Friedewald formula underestimates LDL cholesterol at low concentrations.
    Scharnagl H; Nauck M; Wieland H; März W
    Clin Chem Lab Med; 2001 May; 39(5):426-31. PubMed ID: 11434393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of endogenous steroid levels with high and low density lipoprotein concentrations in the human maternal-fetoplacental unit at term.
    Nayar S; Reggio BC; Henson MC
    J Reprod Med; 1996 Feb; 41(2):91-8. PubMed ID: 8656421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lipoprotein (a) and the evaluation of low density cholesterol by the Friedewald formula: a new problem for an old equation].
    Hernández C; Chacón P; García-Pascual L; Rosselló J; Simó R
    Med Clin (Barc); 1999 Sep; 113(8):290-1. PubMed ID: 10603581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The accuracy in using modified Friedewald equation to calculate LDL from non-fast triglyceride: a pilot study.
    Puavilai W; Laorugpongse D; Deerochanawong C; Muthapongthavorn N; Srilert P
    J Med Assoc Thai; 2009 Feb; 92(2):182-7. PubMed ID: 19253792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults.
    Takeuchi T; Nemoto K; Takahashi O; Urayama KY; Deshpande GA; Izumo H
    J Clin Lipidol; 2014; 8(5):501-9. PubMed ID: 25234563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.